Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 5/2018

16.03.2018 | Retinal Disorders

Prevalence of choroidal nevus and retinal pigment epithelial alterations in vitiligo patients

verfasst von: Efrat Fleissig, Mor Pavlovksy, Anat Loewenstein, Dinah Zur, Hadas Newman, Shay Keren, Dafna Goldenberg, Efrat Bar-Ilan, Michaella Goldstein

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To investigate ocular manifestations in patients with vitiligo by multimodal imaging, including optical coherence tomography (OCT), color fundus photography, and fundus autofluorescence (FAF).

Methods

In this prospective, observational clinical study, vitiligo patients underwent ophthalmologic and dermatologic clinical assessment and imaging by spectral-domain OCT, FAF, and color fundus imaging. Ocular echography was performed as indicated. Statistical analysis was performed using paired T test and Pearson correlation.

Results

A total of 61 eyes of 31 vitiligo patients were examined. Ocular findings consisted of choroidal nevi (n = 10, 32%), of which four (40%) were bilateral; two patients (6.5%) had a prominent choroidal pattern, two (6.5%) had hypopigmentary retinal pigment epithelium (RPE) lesions, and one (3.2%) had peripapillary atrophy of the RPE. Choroidal nevi were demonstrated only in eyes of patients with generalized vitiligo and were more common with upper body involvement (p = 0.02) and more prevalent in women (p = 0.02). Hypopigmentary lesions were detected in two patients and demonstrated on OCT as RPE atrophy and as photoreceptor/RPE changes.

Conclusions

In this case series, vitiligo patients had a higher rate of choroidal nevi than previously reported. The hypopigmentary vitiliginous fundus lesions were depicted on OCT as photoreceptor and RPE atrophy. These findings may suggest the advisability of regular ocular monitoring for vitiligo patients.
Literatur
2.
Zurück zum Zitat Njoo MD, Westerhof W (2001) Vitiligo. Pathogenesis and treatment. Am J Clin Dermatol 2:167–181CrossRefPubMed Njoo MD, Westerhof W (2001) Vitiligo. Pathogenesis and treatment. Am J Clin Dermatol 2:167–181CrossRefPubMed
3.
Zurück zum Zitat Birlea SA, Spritz RA, Norris DA (2012) Vitiligo. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K (eds) Fitzpatrick’s dermatology in general medicine, 8th edn. New York, pp 792–803 Birlea SA, Spritz RA, Norris DA (2012) Vitiligo. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K (eds) Fitzpatrick’s dermatology in general medicine, 8th edn. New York, pp 792–803
4.
Zurück zum Zitat Cowan CL Jr, Halder RM, Grimes PE, Chakrabarti SG, Kenney JA Jr (1986) Ocular disturbances in vitiligo. J Am Acad Dermatol 15:17–24CrossRefPubMed Cowan CL Jr, Halder RM, Grimes PE, Chakrabarti SG, Kenney JA Jr (1986) Ocular disturbances in vitiligo. J Am Acad Dermatol 15:17–24CrossRefPubMed
5.
Zurück zum Zitat Albert DM, Wagoner MD, Pruett RC, Nordlund JJ, Lerner AB (1983) Vitiligo and disorders of the retinal pigment epithelium. Br J Ophthalmol 67:153–156CrossRefPubMedPubMedCentral Albert DM, Wagoner MD, Pruett RC, Nordlund JJ, Lerner AB (1983) Vitiligo and disorders of the retinal pigment epithelium. Br J Ophthalmol 67:153–156CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Karadag R, Esmer O, Karadag AS, Bilgili SG, Cakici O, Demircan YT, Bayramlar H (2016) Evaluation of ocular findings in patients with vitiligo. Int J Dermatol 55:351–355CrossRefPubMed Karadag R, Esmer O, Karadag AS, Bilgili SG, Cakici O, Demircan YT, Bayramlar H (2016) Evaluation of ocular findings in patients with vitiligo. Int J Dermatol 55:351–355CrossRefPubMed
7.
Zurück zum Zitat Albert DM, Nordlund JJ, Lerner AB (1979) Ocular abnormalities occurring with vitiligo. Ophthalmology 86:1145–1160CrossRefPubMed Albert DM, Nordlund JJ, Lerner AB (1979) Ocular abnormalities occurring with vitiligo. Ophthalmology 86:1145–1160CrossRefPubMed
8.
Zurück zum Zitat Bulbul Baskan E, Baykara M, Ercan I, Tunali S, Yucel A (2006) Vitiligo and ocular findings: a study on possible associations. J Eur Acad Dermatol Venereol 20:829–833PubMed Bulbul Baskan E, Baykara M, Ercan I, Tunali S, Yucel A (2006) Vitiligo and ocular findings: a study on possible associations. J Eur Acad Dermatol Venereol 20:829–833PubMed
9.
Zurück zum Zitat Perossini M, Turio E, Perossini T, Cei G, Barachini P (2010) Vitiligo: ocular and electrophysiological findings. Ital Dermatol Venereol 145:141–149 Perossini M, Turio E, Perossini T, Cei G, Barachini P (2010) Vitiligo: ocular and electrophysiological findings. Ital Dermatol Venereol 145:141–149
11.
Zurück zum Zitat Singh AD, Kalyani P, Topham A (2005) Estimating the risk of malignant transformation of a choroidal nevus. Ophthalmology 112:1784–1789CrossRefPubMed Singh AD, Kalyani P, Topham A (2005) Estimating the risk of malignant transformation of a choroidal nevus. Ophthalmology 112:1784–1789CrossRefPubMed
12.
Zurück zum Zitat Sumich P, Mitchell P, Wang JJ (1998) Choroidal nevi in a white population: the Blue Mountains Eye Study. Arch Ophthalmol 116:645–650CrossRefPubMed Sumich P, Mitchell P, Wang JJ (1998) Choroidal nevi in a white population: the Blue Mountains Eye Study. Arch Ophthalmol 116:645–650CrossRefPubMed
13.
Zurück zum Zitat Qiu M, Shields CL (2015) Choroidal nevus in the United States adult population: racial disparities and associated factors in the National Health and Nutrition Examination Survey. Ophthalmology 122:2071–2083CrossRefPubMed Qiu M, Shields CL (2015) Choroidal nevus in the United States adult population: racial disparities and associated factors in the National Health and Nutrition Examination Survey. Ophthalmology 122:2071–2083CrossRefPubMed
14.
Zurück zum Zitat Gordon-Shaag A, Barnard S, Millodot M, Gantz L, Chiche G, Vanessa E, Ruth W, Pinchasov R, Gosman Z, Simchi M, Koslowe K, Shneor E (2014) Prevalence of choroidal naevi using scanning laser ophthalmoscope. Ophthalmic Physiol Opt 34:94–101CrossRefPubMed Gordon-Shaag A, Barnard S, Millodot M, Gantz L, Chiche G, Vanessa E, Ruth W, Pinchasov R, Gosman Z, Simchi M, Koslowe K, Shneor E (2014) Prevalence of choroidal naevi using scanning laser ophthalmoscope. Ophthalmic Physiol Opt 34:94–101CrossRefPubMed
15.
Zurück zum Zitat Nordlund JJ, Kirkwood JM, Forget BM, Milton G, Albert DM, Lerner AB (1983) Vitiligo in patients with metastatic melanoma: a good prognostic sign. J Am Acad Dermatol 9:689–696CrossRefPubMed Nordlund JJ, Kirkwood JM, Forget BM, Milton G, Albert DM, Lerner AB (1983) Vitiligo in patients with metastatic melanoma: a good prognostic sign. J Am Acad Dermatol 9:689–696CrossRefPubMed
16.
17.
Zurück zum Zitat Lerner AB, Nordlund JJ (1977) Should vitiligo be induced in patients after resection of primary melanoma? Arch Dermatol 113:421CrossRefPubMed Lerner AB, Nordlund JJ (1977) Should vitiligo be induced in patients after resection of primary melanoma? Arch Dermatol 113:421CrossRefPubMed
18.
Zurück zum Zitat Albert DM, Todes-Taylor N, Wagoner M, Nordlund JJ, Lerner AB (1982) Vitiligo or halo nevi occurring in two patients with choroidal melanoma. Arch Dermatol 118:34–36CrossRefPubMed Albert DM, Todes-Taylor N, Wagoner M, Nordlund JJ, Lerner AB (1982) Vitiligo or halo nevi occurring in two patients with choroidal melanoma. Arch Dermatol 118:34–36CrossRefPubMed
19.
Zurück zum Zitat Shields CL, Maktabi AM, Jahnle E, Mashayekhi A, Lally SE, Shields JA (2010) Halo nevus of the choroid in 150 patients: the 2010 Henry van dyke lecture. Arch Ophthalmol 128:859–864CrossRefPubMed Shields CL, Maktabi AM, Jahnle E, Mashayekhi A, Lally SE, Shields JA (2010) Halo nevus of the choroid in 150 patients: the 2010 Henry van dyke lecture. Arch Ophthalmol 128:859–864CrossRefPubMed
20.
Zurück zum Zitat Patrizi A, Bentivogli M, Raone B, Dondi A, Tabanelli M, Neri I (2013) Association of halo nevus/I and vitiligo in childhood: a retrospective observational study. J Eur Acad Dermatol Venereol 27:48–52CrossRef Patrizi A, Bentivogli M, Raone B, Dondi A, Tabanelli M, Neri I (2013) Association of halo nevus/I and vitiligo in childhood: a retrospective observational study. J Eur Acad Dermatol Venereol 27:48–52CrossRef
21.
Zurück zum Zitat Rodrigues M, Ezzedine K, Hamzavi I, Pandya AG, Harris JE, Vitiligo Working Group (2017) New discoveries in the pathogenesis and classification of vitiligo. J Am Acad Dermatol 77:1–13CrossRefPubMed Rodrigues M, Ezzedine K, Hamzavi I, Pandya AG, Harris JE, Vitiligo Working Group (2017) New discoveries in the pathogenesis and classification of vitiligo. J Am Acad Dermatol 77:1–13CrossRefPubMed
22.
Zurück zum Zitat Kemp EH, Emhemad S, Akhtar S, Watson PF, Gawkrodger DJ, Weetman AP (2011) Autoantibodies against tyrosine hydroxylase in patients with non-segmental (generalised) vitiligo. Exp Dermatol 20:35–40CrossRefPubMed Kemp EH, Emhemad S, Akhtar S, Watson PF, Gawkrodger DJ, Weetman AP (2011) Autoantibodies against tyrosine hydroxylase in patients with non-segmental (generalised) vitiligo. Exp Dermatol 20:35–40CrossRefPubMed
23.
Zurück zum Zitat Kemp EH, Waterman EA, Gawkrodger DJ, Watson PF, Weetman AP (1998) Autoantibodies to tyrosinase-related protein-1 detected in the sera of vitiligo patients using a quantitative radiobinding assay. Br J Dermatol 139:798–805CrossRefPubMed Kemp EH, Waterman EA, Gawkrodger DJ, Watson PF, Weetman AP (1998) Autoantibodies to tyrosinase-related protein-1 detected in the sera of vitiligo patients using a quantitative radiobinding assay. Br J Dermatol 139:798–805CrossRefPubMed
24.
Zurück zum Zitat Kemp EH, Gawkrodger DJ, Watson PF, Weetman AP (1997) Immunoprecipitation of melanogenic enzyme autoantigens with vitiligo sera: evidence for cross-reactive autoantibodies to tyrosinase and tyrosinase-related protein-2 (TRP-2). Clin Exp Immunol 109:495–500CrossRefPubMedPubMedCentral Kemp EH, Gawkrodger DJ, Watson PF, Weetman AP (1997) Immunoprecipitation of melanogenic enzyme autoantigens with vitiligo sera: evidence for cross-reactive autoantibodies to tyrosinase and tyrosinase-related protein-2 (TRP-2). Clin Exp Immunol 109:495–500CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Baharav E, Merimski O, Shoenfeld Y, Zigelman R, Gilbrud B, Yecheskel G, Youinou P, Fishman P (1996) Tyrosinase as an autoantigen in patients with vitiligo. Clin Exp Immunol 105:84–88CrossRefPubMedPubMedCentral Baharav E, Merimski O, Shoenfeld Y, Zigelman R, Gilbrud B, Yecheskel G, Youinou P, Fishman P (1996) Tyrosinase as an autoantigen in patients with vitiligo. Clin Exp Immunol 105:84–88CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Nakamura Y, Tanaka R, Asami Y, Teramoto Y, Imamura T, Sato S, Maruyama H, Fujisawa Y, Matsuya T, Fujimoto M, Yamamoto A (2017) Correlation between vitiligo occurrence and clinical benefit in advanced melanoma patients treated with nivolumab: a multi-institutional retrospective study. J Dermatol 44:117–122CrossRefPubMed Nakamura Y, Tanaka R, Asami Y, Teramoto Y, Imamura T, Sato S, Maruyama H, Fujisawa Y, Matsuya T, Fujimoto M, Yamamoto A (2017) Correlation between vitiligo occurrence and clinical benefit in advanced melanoma patients treated with nivolumab: a multi-institutional retrospective study. J Dermatol 44:117–122CrossRefPubMed
27.
Zurück zum Zitat Hann SK, Lee HJ (1996) Segmental vitiligo: clinical findings in 208 patients. J Am Acad Dermatol 35:671–674CrossRefPubMed Hann SK, Lee HJ (1996) Segmental vitiligo: clinical findings in 208 patients. J Am Acad Dermatol 35:671–674CrossRefPubMed
28.
Zurück zum Zitat Margolis R, Spaide RF (2009) A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am J Ophthalmol 147:811–815CrossRefPubMed Margolis R, Spaide RF (2009) A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am J Ophthalmol 147:811–815CrossRefPubMed
29.
Zurück zum Zitat Fujiwara T, Imamura Y, Margolis R, Slakter JS, Spaide RF (2009) Enhanced depth imaging optical coherence tomography of the choroid in highly myopic eyes. Am J Ophthalmol 148:445–450CrossRefPubMed Fujiwara T, Imamura Y, Margolis R, Slakter JS, Spaide RF (2009) Enhanced depth imaging optical coherence tomography of the choroid in highly myopic eyes. Am J Ophthalmol 148:445–450CrossRefPubMed
Metadaten
Titel
Prevalence of choroidal nevus and retinal pigment epithelial alterations in vitiligo patients
verfasst von
Efrat Fleissig
Mor Pavlovksy
Anat Loewenstein
Dinah Zur
Hadas Newman
Shay Keren
Dafna Goldenberg
Efrat Bar-Ilan
Michaella Goldstein
Publikationsdatum
16.03.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 5/2018
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-018-3958-0

Weitere Artikel der Ausgabe 5/2018

Graefe's Archive for Clinical and Experimental Ophthalmology 5/2018 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.